A venture capital and private equity firm invests in breakthrough industrial technologies and, within the life sciences, is looking to invest in companies developing R&D and manufacturing tools and services. The firm is interested in companies that have at least some data through a pilot or a pharma partner to validate their technology. The firm invests primarily in North America-based companies, but will consider international companies that have significant operations in the US.
The firm invests in tools and services for R&D and manufacturing within the life sciences. This can include diagnostics platforms, AI/ML based drug discovery platforms, analytics or manufacturing tools. The firm invests primarily in technologies that do not require FDA approval, and looks for companies with some data validation of their technology with an external partner.
The firm prefers to lead and take a board seat when investing, but will occasionally co-invest as well. The firm will also consider follow-on investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply